Holzer & Holzer, LLC is investigating whether Northwest Biotherapeutics,
Inc. (“Northwest Bio” or the “Company”) (NASDAQ: NWBO) and/or certain of
its officers complied with the federal securities laws in making public
statements regarding its experimental cancer vaccine, DCVax-Direct.
for - Investor Alert: Investigation into Northwest Biotherapeutics, Inc. Announced by Holzer & Holzer, LLC investment picks